Thursday, May 12, 2022 10:01:48 PM
Once a drug is in phase 3, we may also make that medicine available under Federal and State Right to Try laws, upon request of patients, families, and the treating physicians, provided our medical consultants concur that our investigational products have a reasonable likelihood of an acceptable risk-benefit for the patient.
At this time, NRx Pharmaceuticals is able to provide limited access, on a case-by-case basis, to its investigational medicine Aviptadil through the Aviptadil Right to Try Program. Patients considered for this program would need to meet the following minimum requirements for access:
—-Patients who have a serious disease or condition and whose life is immediately threatened by this disease or condition.
—-Critical COVID-19 meets this standard.
Patients who have no comparable or satisfactory therapy to treat their disease or condition.
—-Patients who are unable or ineligible to participate in a clinical trial involving Aviptadil
For more information, please contact us at ZyesamiRTT@nrxpharma.com.
The Aviptadil Right to Try Program is subject to drug availability and medical review by NRx Pharmaceuticals. NRx Pharmaceuticals has selected Clinigen to administer the Aviptadil Right to Try Program. All requests for Aviptadil under the Aviptadil Right to Try Program must be made by the patient’s treating physician, by completing this application form:
https://www.nrxpharma.com/right-to-try/
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM